CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


NO-ImmunosuppressiveWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug1226 Schirmer Test I Wiki 1.00
drug665 Immunoglubulins Wiki 1.00
drug667 Immunosuppressive Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D003231 Conjunctivitis NIH 0.71

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0000509 Conjunctivitis HPO 0.71

There is one clinical trial.

Clinical Trials


1 Effect of Immunosupressive Treatment in COVID-19 Patients Whit SAM-LIKE Profile: Retrospective Cohort Study (SAM-COVID Project)

SAM-COVID is a retrospective cohort study that aims to determine the impact of immunosuppressive drugs and immunoglubulins in the outcome of patients with COVID-19.

NCT04382781 COVID-19 Infection Drug: NO-Immunosuppressive Drug: Immunosuppressive Drug: Immunoglubulins

Primary Outcomes

Description: Days until invasive mechanical ventilation or death, whatever happened first.

Measure: Invasive ventilation or death

Time: Up to 21 days

Secondary Outcomes

Description: Days until mechanical ventilation

Measure: Ventilation

Time: Up to 21 days

Description: Days until death

Measure: Death

Time: Up to 21 days

Description: Proportion of patients developing secondary infections

Measure: Secondary infections

Time: Up to 21 days

Description: Proportion of patients with digestive tract hemorrhage

Measure: Digestive tract hemorrhage

Time: Up to 21 days

Description: Proportion of patients with imnprovement in 2 or more points in 7-point scale by WHO

Measure: Change in 7 points scale

Time: Day 21


No related HPO nodes (Using clinical trials)